SCHEMBL18253757

SCHEMBL18253757

O=P(c1ccccc1)(c1ccccc1)c1ccc(-c2c3ccc4ccccc4c3cc3c2ccc2ccccc23)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SOS1 Q07889 2/20 0.37
▸ HPRT1 P00492 4/20 0.34
▸ CYP2C9 P11712 4/20 0.33
▸ LMNA P02545 4/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ HIF1A Q16665 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18253762 0.90 SOS1 (0.37) SOS1HPRT1CYP2C9LMNAALDH1A1
SCHEMBL18253765 0.88 HPRT1 (0.37) SOS1HPRT1CYP2C9LMNAALDH1A1
SCHEMBL21503934 0.81 LDHA (0.36) LMNAMEN1KMT2AMAPTMAPK1
SCHEMBL18253748 0.81 SOS1 (0.41) SOS1HPRT1CYP2C9LMNAALDH1A1
SCHEMBL18253744 0.81 SOS1 (0.41) SOS1HPRT1CYP2C9LMNAALDH1A1
SCHEMBL18253841 0.79 PTPN2 (0.38) LMNATOP1
SCHEMBL18253796 0.79 SOS1 (0.41) SOS1HPRT1CYP2C9LMNAALDH1A1
SCHEMBL18253779 0.77 GPR84 (0.32) CYP2C9LMNA
SCHEMBL14076802 0.77 LMNA (0.44) LMNAALDH1A1MEN1KMT2A
SCHEMBL17034900 0.77 CYP2C9 (0.33) CYP2C9LMNAMAPTNPC1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160343950-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-11-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160343950-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE TERT, PIEZO1, ETV6 SOS1 468/4885HPRT1 670/4885CYP2C9 1021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback